Role of Panchkarma in Gout

CLINICAL EVALUATION OF AMRUTADYA TAIL MATRA BASTI IN THE MANAGEMENT OF VATARAKTA

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/014308

Enrollment

Registered

2018-05-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Gout Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Maatra Basti: Amrutadi Taila 50ml though anal route total duration of therapy 60 days Control Intervention1: Allopurinol Tablet: 150 mg BD

Eligibility

Inclusion criteria

Inclusion criteria: Fulfilling Diagnostic Criteria of vatarakta

Exclusion criteria

Exclusion criteria: Secondary Hyperuricemia.

Design outcomes

Primary

Measure	Time frame
â?¢ Marked improvement : 0% to 25 % â?¢ Moderate improvement : 25 % to 50 % â?¢ Mild improvement : 50% to 75 % â?¢ No improvement : 75% to 100% Timepoint: â?¢ Marked improvement : 0% to 25 % â?¢ Moderate improvement : 25 % to 50 % â?¢ Mild improvement : 50% to 75 % â?¢ No improvement : 75% to 100%	—

Secondary

Measure	Time frame
â?¢ Marked improvement : 0% to 25 % â?¢ Moderate improvement : 25 % to 50 % â?¢ Mild improvement : 50% to 75 % â?¢ No improvement : 75% to 100% Timepoint: â?¢ Marked improvement : 0% to 25 % â?¢ Moderate improvement : 25 % to 50 % â?¢ Mild improvement : 50% to 75 % â?¢ No improvement : 75% to 100%	—

Countries

India

Contacts

Public ContactDr Rajesh Kumar Dharua

Uttarakhand Ayurved University

dharuarajeshkumar@gmail.com8763835909

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026